Navigation Links
AEterna Zentaris Reports First Quarter 2009 Financial and Operating Results
Date:5/6/2009

l industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements, and we disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments except if we are requested to do so by a governmental authority or applicable law.

Attachment: Financial summary

    Quarterly Consolidated Statements of Loss (unaudited)

                                                     Quarters ended March 31,
    -------------------------------------------------------------------------
    (in thousands, except per share data)                 2009          2008
    -------------------------------------------------------------------------
    -------------------------------------------------------------------------
                                                           $             $
    Revenues
    Sales and royalties                                  4,971         7,942
    License fees and other                               1,140         1,806
    -------------------------------------------------------------------------
                                                         6,111         9,748
    -------------------------------------------------------------------------
    Operating expenses
    Cost of sales                                        3,694         4,604
    Research and development costs, net of tax
     credits and grants                                 11,437        13,689
'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. AEterna Zentaris to Announce Third Quarter 2007 Financial and Operating Results on November 7, 2007
2. AEterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... (PRWEB) March 04, 2015 In the Ultimate ... fight that is the main event. For UFC 189 ... fight will be for the UFC Featherweight Championship. Brazilian champion ... often out-spoken native of Ireland, Conor “Notorious” McGregor. UFC 189 ... Garden Arena in Las Vegas, NV. , When it comes ...
(Date:3/4/2015)... 04, 2015 When people talk about venues ... artists spread across numerous genres, the Houston Rodeo ... Each night during the annual livestock show and rodeo, one ... the other activities being held at the event. The 2015 ... performers that will try and get the festival its largest ...
(Date:3/4/2015)... March 04, 2015 TROY Healthcare Solutions ... which provides the ultimate level of security for prescriptions, ... Hilton Houston Plaza Medical Center located at 6633 Travis ... Beginning at 7 AM, TROY Healthcare Solutions will host ... Solutions will offer brief presentations each hour to introduce ...
(Date:3/4/2015)... March 04, 2015 The ability ... in density assessment and help improve breast cancer ... abstracts accepted for presentation at the European Congress ... Ten abstracts - eight posters and 2 session ... automated breast density and quantitative breast imaging software ...
(Date:3/4/2015)... Concord, NH (PRWEB) March 04, 2015 ... the natural frozen food category, will attend this year’s ... from its newest product line. With this new line, ... meals in the natural channel, continues its commitment to ... the fastest growing frozen brand in the natural channel, ...
Breaking Medicine News(10 mins):Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 2Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 3Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 2Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 3Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 5Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 2Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 3
... Minn. -- The Medical Publishing Insights and Practices ... journal editors to characterize the persistent and perceived ... identify potential approaches to resolve it. This unique ... Ten Recommendations for Closing the Credibility Gap in ...
... By Randy Dotinga HealthDay Reporter , MONDAY, May ... front of the TV have poorer diets overall, a new study ... that TV watching has anything to do with what kids eat, ... more important than time spent with "American Idol" or "SpongeBob SquarePants." ...
... -- Giving earplugs to patients in the intensive care unit ... onset of delirium, according to a new study. It ... delirium in ICU patients, and research has shown that ICU ... in the ICU from equipment and people coming and going. ...
... hard to diagnose as well as treat, but researchers at ... discovered a way of confirming the disorder using stool samples. ... with pain and discomfort in the abdomen together with changes ... to be linked to dysfunction of the stomach and intestines, ...
... risk of prostate cancer can be beneficial in reducing ... states an article published in CMAJ ( ... Preventive Services Task Force, which last issued prostate screening ... prostate-specific antigen (PSA) screening for men of all ages. ...
... Professor Keon Jae Lee ( http://fand.kaist.ac.kr/ ) from ... has developed new forms of low cost, large-area ... Piezoelectric effects-based nanogenerator technology that converts existing sources ... energy from the nature of wind and waves, ...
Cached Medicine News:Health News:Journals and pharma collaborate on new recommendations 2Health News:Lots of TV May Harm Kids' Diet 2Health News:Lots of TV May Harm Kids' Diet 3Health News:Using Earplugs Eases ICU Patients' Confusion: Study 2Health News:PSA screening to detect prostate cancer can be beneficial to younger and at-risk men 2
(Date:3/4/2015)... , March 4, 2015   Aratana Therapeutics, ... therapeutics company focused on the licensing, development and commercialization ... that it will present at the Barclays Global ... at the Loews Miami Beach Hotel in ... St. Peter , M.D., President and Chief Executive Officer ...
(Date:3/4/2015)... --Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in developing targeted ... announced that James A. Joyce , Aethlon Medical ... the 27th Annual ROTH Conference on March 10, 2015 ... California . To learn more about the ROTH ... live webcast of the presentation will be available on ...
(Date:3/4/2015)... 4, 2015  Heska Corporation (Nasdaq: HSKA ... to Join Its Fourth Quarter and Year End 2014 ... @ 9:00 a.m. (MST) / 11:00 a.m. (EST)Where: www.heska.com ... Earnings Call link on the front page of this ... the web at the address above.  Alternatively, you may ...
Breaking Medicine Technology:Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2Aethlon Medical to Present at the 27th Annual ROTH Conference 2Webcast Alert: Heska Announces Fourth Quarter and Year End 2014 Earnings Conference Call Webcast 2
... Lexicon Pharmaceuticals, Inc. (Nasdaq: ... developing breakthrough treatments for human disease, today updated its ... three months ended March 31, 2011.   ... progress.  Results from a mechanistic study of a tablet ...
... Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) today ... the U.S. Food and Drug Administration (the "FDA") after carefully ... the reviews of the New Drug Application (the "NDA") for ... March 22, 2010 Oncology Drugs Advisory Committee meeting and consulting ...
Cached Medicine Technology:Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results 2Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results 3Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results 4Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results 5Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results 6Cell Therapeutics to Re-submit Pixantrone NDA in Consideration for Accelerated Approval in Accordance with Guidance from FDA's Office of New Drugs 2Cell Therapeutics to Re-submit Pixantrone NDA in Consideration for Accelerated Approval in Accordance with Guidance from FDA's Office of New Drugs 3Cell Therapeutics to Re-submit Pixantrone NDA in Consideration for Accelerated Approval in Accordance with Guidance from FDA's Office of New Drugs 4Cell Therapeutics to Re-submit Pixantrone NDA in Consideration for Accelerated Approval in Accordance with Guidance from FDA's Office of New Drugs 5
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 11 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 6.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 12 mm....
Medicine Products: